Analystreport

Millendo Therapeutics Inc (NASDAQ: MLND) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Millendo Therapeutics, Inc. - Common Stock  (MLND) 
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am Check Earnings Report